Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. - Wikidata - wikimedia - TriplyDB

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

http://www.wikidata.org/entity/Q35845324

about

Microbiome mediation of infections in the cancer setting Bacterial Infections in Hematopoietic Stem Cell Transplant Recipients Possible implication of bacterial infection in acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation Intestinal dysbiosis and allogeneic hematopoietic progenitor cell transplantation Clostridium difficile Infection in Special High-Risk Populations Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Infections in Hematopoietic Cell Transplant Recipients: Results From the Organ Transplant Infection Project, a Multicenter, Prospective, Cohort Study Hematologic diseases: high risk of Clostridium difficile associated diarrhea Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals Incidence of diarrhea by Clostridium difficile in hematologic patients and hematopoietic stem cell transplantation patients: risk factors for severe forms and death.The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.Clostridium difficile infection among hematopoietic stem cell transplant recipients: beyond colitis.High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation.Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.Clostridium difficile infection among hospitalized HIV-infected individuals: epidemiology and risk factors: results from a case-control study (2002-2013).Risk factors for recurrent hospital-acquired Clostridium difficile infection in a Japanese university hospital.Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer.Antibiotic therapy and Clostridium difficile infection - primum non nocere - first do no harm Evaluating risk factors for Clostridium difficile infection in adult and pediatric hematopoietic cell transplant recipients Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation.Epidemiology, risk factors, and outcomes of Clostridium difficile infection in kidney transplant recipients.Clostridium difficile infection after allogeneic hematopoietic stem cell transplant: strain diversity and outcomes associated with NAP1/027.Transmission of Clostridium difficile During Hospitalization for Allogeneic Stem Cell Transplant.Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea Clostridium difficile infection after adult autologous stem cell transplantation: a multicenter study of epidemiology and risk factors.Clostridium difficile in a HIV-infected cohort: incidence, risk factors, and clinical outcomes Community-acquired Clostridium difficile infection: an increasing public health threat.Early infections after autologous hematopoietic stem cell transplantation in children and adolescents: the St. Jude experience Risk for Clostridium difficile Infection After Allogeneic Hematopoietic Cell Transplant Remains Elevated in the Postengraftment Period.Delayed opportunistic infections in hematopoietic stem cell transplantation patients: a surmountable challenge The prevention and management of infections due to multidrug resistant organisms in haematology patients Clostridium difficile: deleterious impact on hematopoietic stem cell transplantation.Clostridium difficile infection in the pediatric transplant patient.The epidemiology of Clostridium difficile infection in patients with cancer.The Role of Biomarkers in the Diagnosis and Risk Stratification of Acute Graft-versus-Host Disease: A Systematic Review.Evaluating Risk Factors for Clostridium difficile Infection In Stem Cell Transplant Recipients: A National Study.Epidemiology of infections following haploidentical peripheral blood hematopoietic cell transplantation.The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens.

P2860

Q26752672-2CDE5D24-0663-49D4-89A4-CC1FC7803EAD Q26799576-70A07656-5E10-4E5B-A0BD-AFA742E4947B Q27001015-8D6711F7-B636-4134-B648-9DA27AC673C9 Q28067459-57981860-5DAB-4C54-9A24-E7B7BA174F36 Q28069414-C492C92D-D191-41B7-AED9-D1FD91610897 Q30238945-7FAE1D96-CE3C-4882-9FB8-6CB66BF821CB Q33641898-2459416E-9834-4B94-80E3-0A8F5C8AC3B4 Q33718326-9E4EA3CE-1C7C-4DA2-992D-77B09F35BE3D Q33827614-44B124FB-A75F-41B6-99FB-9EFF4E921948 Q34040801-667EFD55-8489-4A03-8DC2-0A57B36FEC44 Q34047880-AF82B6F6-FF43-4DBD-8322-FDD7F52C8F57 Q34461701-EB9DF7FC-61D9-4BC7-B215-BDC0904B6C6C Q34802425-A0835DA1-ADB5-4719-91F2-B293E41BFDEA Q35129079-258FC74C-7545-4B31-B71F-6EBB528893FB Q35534395-06D0539D-1AA6-4ABC-88DC-BADC6F30BFFD Q35866318-019CB492-2B45-4788-BFB3-4CAD379019FF Q35997157-4AB2032A-D086-4C7C-B741-1C4E5A2BA81D Q36078316-5785B789-90A9-4FB1-8A6B-C7E94B349DF0 Q36164920-F3D5B6D0-7D70-441F-BA62-3EF666F90C2E Q36370357-A9B0796A-B2E2-4EE2-B19F-23C468C33137 Q36640227-A4CA1132-ADF4-4B75-9C0B-35466F78A7FB Q36856267-B2D80BD2-B015-4E06-9AE7-B31ABEC5F5E4 Q36977948-6BC3B34D-E83F-4662-863F-52BB52A1026C Q36980277-67CAF21E-4896-4A07-8BFA-7CFEE10CB820 Q37035829-ED3C4933-7B8A-44DD-A04E-0E57FDA1E032 Q37124032-8A1A33F1-A8E0-46B2-BD6B-CBA0BCC11017 Q37250343-0CCC024A-277F-4EBE-9192-8E8BFE5D5DFF Q37432696-B3BCA042-BD4A-47C3-8D4B-23740BE6516E Q37655456-A969CE08-C69D-452F-881C-1C6D031A6C4D Q37730177-5437C570-5F90-4E65-992A-5B01F4EFD55F Q37738747-F0BED9DA-A619-4D9F-9066-5C2BB81FE943 Q38066877-9D7236F2-1A98-4F88-841D-2AEBDBE31E48 Q38171538-868C9B64-AD02-4626-BCED-2AC8173869CF Q38175865-125188BE-FB4E-4120-A749-B9CF3693BCB7 Q38592385-797BB476-3899-4271-A895-11C4AD9CA8B5 Q38823326-4217E547-C7E3-4563-9F62-827CF59F8E65 Q38829335-593C0982-6EE1-4AE4-A049-1E3D382A4D09 Q38885621-9FFAAD15-402C-4988-BE3E-2D21E06E2434 Q39058080-E30E10DD-31CE-4936-B222-38E9DBCF4E9C Q40063718-0ECA3A9C-2C57-4C35-B0B6-4F23FA5900F4

P2860

Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

http://www.wikidata.org/entity/Q35845324

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Epidemiology and outcomes of C ...... em cell transplant recipients.

@ast

Epidemiology and outcomes of C ...... em cell transplant recipients.

@en

type

label

Epidemiology and outcomes of C ...... em cell transplant recipients.

@ast

Epidemiology and outcomes of C ...... em cell transplant recipients.

@en

prefLabel

Epidemiology and outcomes of C ...... em cell transplant recipients.

@ast

Epidemiology and outcomes of C ...... em cell transplant recipients.

@en

P1433

Q35845324-46386829-5639-4E57-AC77-8958D86DBF24

P1476

Q35845324-306B2626-78AC-404A-9660-ED724D499E55

P2093

Q35845324-635EFF2A-7CA8-455F-B257-36A1A5FE046D

Q35845324-74C77C02-017B-4617-AC81-48F870A8414B

Q35845324-A77C4424-E875-4214-84CF-CECDB268492E

Q35845324-C0A70B3C-5FCF-45F2-BF0B-67D1D7CD79AD

Q35845324-DD246EEA-018E-4F78-A65B-1778B6CC19FC

Q35845324-DDF6FD6C-5C10-4483-8191-5D2E6D6F7EE7

P2860

Q35845324-03A28FB0-520C-46CE-BCF5-76E44A4C88DC

Q35845324-0D771901-668C-4DC1-B8E5-5876070E421F

Q35845324-1898AD99-11DC-4D9E-9680-86054B909B82

Q35845324-1CD9159C-B53B-4020-88CF-DBD2BD518A24

Q35845324-295E63A8-3E8E-4923-9E34-33873E0F19A8

Q35845324-2B4FD248-DAC1-4F09-A0F8-E12B707D54D4

Q35845324-3C35CFD7-4D91-43B9-B935-1DBB596AA94E

Q35845324-3EB39C3C-7229-467A-86B7-E1FF05A013CC

Q35845324-4882706D-982F-46AA-9807-4A241D1D8F02

Q35845324-550B2BEE-0C5F-4ABD-AF66-94480A2BF5D2

P304

Q35845324-04412C97-E8CB-4DC1-AF1A-0001C332F406

P31

Q35845324-70F1604B-CF27-4940-955C-6BD154DBC6E7

P356

Q35845324-A906784E-1B46-4D05-8248-52D2ED0ABC70

P407

Q35845324-18A4C344-1318-450F-B2E5-7A99FE1450BE

P433

Q35845324-D06E4C03-ECC1-4A2D-AA0D-747E64221ADD

P478

Q35845324-120A127C-7A83-4FE8-A1D1-43205F3FEEB7

P50

Q35845324-CE7D35D8-2E46-481D-8380-3B8BBE52934C

P577

Q35845324-0DCD50A6-1BF6-470B-9B29-37787F02DCD3

P5875

Q35845324-9AFEF6AD-A83E-400E-A121-C1CFBEC6D57E

P698

Q35845324-94A8F98E-A9BA-409C-BFDD-9700DA270701

P921

Q35845324-8921C80F-EF6F-41B6-8F72-69CBB5C43440

P932

Q35845324-41B234EE-4461-449D-9D02-92192841A376

P356

P1433

Clinical Infectious Diseases

P1476

Epidemiology and outcomes of C ...... tem cell transplant recipients

@en

P2093

Carol Ann Huff

http://www.w3.org/2001/XMLSchema#string

Carolyn D Alonso

http://www.w3.org/2001/XMLSchema#string

David B Hanna

http://www.w3.org/2001/XMLSchema#string

Karen C Carroll

http://www.w3.org/2001/XMLSchema#string

Kieren A Marr

http://www.w3.org/2001/XMLSchema#string

Suzanne B Treadway

http://www.w3.org/2001/XMLSchema#string

P2860

Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003

Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support

High-dose cyclophosphamide for severe aplastic anemia: long-term follow-up

Increase in Clostridium difficile-related mortality rates, United States, 1999-2004.

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

Fidaxomicin versus vancomycin for Clostridium difficile infection.

An epidemic, toxin gene-variant strain of Clostridium difficile.

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

P304

1053-1063

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CID/CIR1035

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221697872

http://www.w3.org/2001/XMLSchema#string

P698

22412059

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

3309884

http://www.w3.org/2001/XMLSchema#string